We are live on ! Find out more
GWPH

GW Pharmaceuticals Plc American Depositary Shares
GWPH

Delisted

GWPH was delisted on the 4th of May, 2021.

Back to rankings

1 hedge funds and large institutions have $3K invested in GW Pharmaceuticals Plc American Depositary Shares in 2021 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 294 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 297 → 1 (-296)

100% less funds holding in top 10

Funds holding in top 10: 21 → 0 (-21)

100% less capital invested

Capital invested by funds: $5.23B → $3K (-$5.23B)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 294

Holders
1
Holders Change
-296
Holders Change %
-99.66%
% of All Funds
0.02%
Holding in Top 10
–
Holding in Top 10 Change
-21
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
294
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
PCM
Pentwater Capital Management
Florida
-$456M
2
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$325M
3
HI
HBK Investments
Texas
-$292M
4
FCM
Farallon Capital Management
California
-$277M
5
GCL
Glazer Capital LLC
New York
-$212M
Name Holding Trade Value Shares
Change 		Change in
Stake
TRCT
151
Tower Research Capital (TRC)
New York
– -$874K -4,027 Closed
Janney Montgomery Scott
152
Janney Montgomery Scott
Pennsylvania
– -$791K -3,647 Closed
Susquehanna International Group
153
Susquehanna International Group
Pennsylvania
– -$785K -3,617 Closed
IAIM
154
International Assets Investment Management
Florida
– -$522K -3,588 Closed
Connor, Clark & Lunn Investment Management (CC&L)
155
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
– -$750K -3,456 Closed
GI
156
GAMCO Investors
Connecticut
– -$744K -3,432 Closed
PAG
157
Private Advisor Group
New Jersey
– -$597K -2,753 Closed
VCM
158
Vivaldi Capital Management
Illinois
– -$591K -2,727 Closed
Zurich Cantonal Bank
159
Zurich Cantonal Bank
Switzerland
– -$573K -2,643 Closed
Truist Financial
160
Truist Financial
North Carolina
– -$571K -2,635 Closed
TI
161
Telemetry Investments
New York
– -$564K -2,600 Closed
Fidelity Investments
162
Fidelity Investments
Massachusetts
– -$518K -2,390 Closed
KWM
163
Kingsview Wealth Management
Oregon
– -$498K -2,294 Closed
QP
164
Quilter Plc
United Kingdom
– -$477K -2,200 Closed
B
165
Bellecapital
Switzerland
– -$477K -2,199 Closed
BRWA
166
B. Riley Wealth Advisors
Florida
– -$383K -2,132 Closed
SC
167
Solstein Capital
California
– -$462K -2,130 Closed
BC
168
Bridgefront Capital
Texas
– -$459K -2,114 Closed
PPA
169
Parametric Portfolio Associates
Washington
– -$455K -2,098 Closed
CSS
170
Cubist Systematic Strategies
Connecticut
– -$442K -2,039 Closed
S
171
swisspartners
Liechtenstein
– -$435K -2,000 Closed
PA
172
Profund Advisors
Maryland
– -$421K -1,942 Closed
Comerica Bank
173
Comerica Bank
Texas
– -$387K -1,766 Closed
GG
174
Gofen & Glossberg
Illinois
– -$365K -1,685 Closed
SG
175
Somerset Group
Minnesota
– -$360K -1,660 Closed
5 6
7
8 9

GWPH Hedge Fund Activity: Q2 2021 in Review

1 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in GW Pharmaceuticals Plc American Depositary Shares (GWPH) for Q2 2021, worth a combined $3K — down 100% from $5.23B a quarter earlier.

Sellers outnumbered buyers: 294 funds closed out of GWPH and 0 opened new positions — a net loss of 294 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Pentwater Capital Management, exiting entirely with an estimated $456M sold.

  • 1 institutional investor held GW Pharmaceuticals Plc American Depositary Shares (GWPH) as of Q2 2021, down from 297 in Q1 2021.
  • Funds reported $3K of GW Pharmaceuticals Plc American Depositary Shares stock for Q2 2021, down 100% quarter-over-quarter.
  • 0 funds opened new GW Pharmaceuticals Plc American Depositary Shares positions in Q2 2021 and 294 closed out, a net change of -294 holders.
  • The largest GW Pharmaceuticals Plc American Depositary Shares seller in Q2 2021 was Pentwater Capital Management, an estimated $456M sold.

Based on aggregated 13F filings for Q2 2021.